Recent News

• 02.07.2025 - Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
• 01.30.2025 - Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
• 01.28.2025 - Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Recent Filings

• 01.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2025 - EX-99.1 EX-99.1
• 01.30.2025 - 8-K Current report
• 01.29.2025 - 424B4 Prospectus [Rule 424(b)(4)]
• 01.27.2025 - EFFECT Notice of Effectiveness
• 01.27.2025 - S-1/A General form for registration of securities under the Securities Act of 1933